The association between vitamin D deficiency and multiple sclerosis: an updated systematic review and meta-analysis

被引:6
作者
Balasooriya, Namal N. [1 ]
Elliott, Thomas M. [2 ]
Neale, Rachel E. [3 ,4 ]
Vasquez, Paola [1 ]
Comans, Tracy [1 ]
Gordon, Louisa G. [2 ]
机构
[1] Univ Queensland, Fac Med, Ctr Hlth Serv Res, Brisbane, Qld 4006, Australia
[2] QIMR Berghofer Med Res Inst, Populat Hlth Dept, Brisbane, Qld 4006, Australia
[3] QIMR Berghofer Med Res Inst, Dept Populat Hlth, Brisbane, Qld, Australia
[4] QIMR Berghofer Med Res Inst, Dept Computat Biol, Brisbane, Qld, Australia
关键词
Vitamin D; 25-hydroxyvitamin D; Deficiency; Multiple sclerosis; ENVIRONMENTAL RISK-FACTORS; SUN EXPOSURE; PROGRESSION; PREVALENCE; DISABILITY; AUSTRALIA;
D O I
10.1016/j.msard.2024.105804
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Although there is evidence of a link between vitamin D status and risk of multiple sclerosis (MS), there has been no systematic review where the exposure measure was vitamin D deficiency rather than 25 hydroxy vitamin D (25(OH)D) concentration. We conducted an updated systematic review and meta-analysis to estimate the association between vitamin D deficiency, defined in most studies as a serum 25(OH)D concentration of < 50 nmol L-1, and MS. Methods: We searched the MEDLINE, EMBASE, and CINAHL databases to identify relevant publications. We estimated the pooled odds ratio (OR) using a random effects model for the association between vitamin D deficiency and MS, overall and stratified by several factors, including whether or not studies included participants who were taking vitamin D supplements. We also analysed the association between mean 25(OH)D concentration and MS, and used meta-regression to assess the effects of vitamin D supplementation, latitude, age, ethnicity, vitamin D definition and seasonality on the OR estimates. The Newcastle-Ottawa Scale was used to assess study quality. Results: Results were pooled across 14 case-control studies published between 2007 and 2021 (n = 4130 cases, n = 4604 controls). Persons with vitamin D deficiency had a 54 % higher risk of multiple sclerosis than those with sufficient vitamin D status (OR 1.54; 95 % CI 1.05, 2.24). In studies that excluded participants taking vitamin D supplements (N = 7), the OR was 2.19 (95 % CI: 1.44, 3.35), whereas, in studies that did not exclude participants taking supplements, there was no increase in risk (OR 0.82; 95 % CI: 0.43, 1.58). Mean age (R-2 = 27.4 %) and inclusion/exclusion of participants taking supplements (R-2 = 33.4 %) contributed most to variability in the OR of vitamin D deficiency and MS. Conclusion: Vitamin D deficiency is associated with an increased likelihood of multiple sclerosis. Maintaining sufficient vitamin D may be an important modifiable risk factor for MS.
引用
收藏
页数:8
相关论文
共 55 条
[31]   Sun exposure and vitamin D are independent risk factors for CNS demyelination [J].
Lucas, R. M. ;
Ponsonby, A. -L. ;
Dear, K. ;
Valery, P. C. ;
Pender, M. P. ;
Taylor, B. V. ;
Kilpatrick, T. J. ;
Dwyer, T. ;
Coulthard, A. ;
Chapman, C. ;
van der Mei, I. ;
Williams, D. ;
McMichael, A. J. .
NEUROLOGY, 2011, 76 (06) :540-548
[32]   Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in Multiple Sclerosis: A Case-Control Study [J].
Martinez-Hernandez, A. ;
Perez-Guerrero, E. E. ;
Macias-Islas, M. A. ;
Nava-Valdivia, C. A. ;
Villagomez-Vega, A. ;
Contreras-Haro, B. ;
Garcia-Ortega, Y. E. ;
Esparza-Guerrero, Y. ;
Gallardo-Moya, S. G. ;
Gamez-Nava, J. I. ;
Gonzalez-Lopez, L. ;
Oliva-Flores, E. ;
Rodriguez-Jimenez, N. A. ;
Cortes-Enriquez, F. ;
Saldana-Cruz, A. M. .
JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
[33]   Associations of serum 25(OH) vitamin D levels with clinical and radiological outcomes in multiple sclerosis, a systematic review and meta-analysis [J].
Martinez-Lapiscina, Elena H. ;
Mahatanan, Rattanaporn ;
Lee, Chih-Hong ;
Charoenpong, Prangthip ;
Hong, Jia-Pei .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 411
[34]   Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review [J].
McKay, Kyla A. ;
Jahanfar, Shayesteh ;
Duggan, Tom ;
Tkachuk, Stacey ;
Tremlett, Helen .
NEUROTOXICOLOGY, 2017, 61 :189-212
[35]   EPIDEMIOLOGY OF MULTIPLE-SCLEROSIS IN AUSTRALIA - WITH NSW AND SA SURVEY RESULTS [J].
MCLEOD, JG ;
HAMMOND, SR ;
HALLPIKE, JF .
MEDICAL JOURNAL OF AUSTRALIA, 1994, 160 (03) :117-&
[36]  
Moher D., 2010, INT J SURG LONDON EN, V8, P336, DOI [10.1016/j.ijsu.2010.02.007, DOI 10.1016/J.IJSU.2010.02.007]
[37]   Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis [J].
Munger, Kassandra L. ;
Levin, Lynn I. ;
Hollis, Bruce W. ;
Howard, Noel S. ;
Ascherio, Alberto .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (23) :2832-2838
[38]   Economic Burden of Multiple Sclerosis A Systematic Review of the Literature [J].
Naci, Huseyin ;
Fleurence, Rachael ;
Birt, Julie ;
Duhig, Amy .
PHARMACOECONOMICS, 2010, 28 (05) :363-379
[39]  
Nelson L.M., 2004, Neuroepidemiol.: From Principl. Pract., P188, DOI [10.1093/acprof:oso/9780195133790.003.08, DOI 10.1093/ACPROF:OSO/9780195133790.003.08]
[40]  
Nikanfar M, 2015, IRAN J NEUROL, V14, P17